Access Campaign


Tag: Access Campaign

MSF reveals cost of its landmark TB clinical trial: €34 million

MSF urges public and non-profit actors to publish clinical trial costs to improve access to medical products for all. Geneva, 25 April 2024 - At the 5th WHO Pharmaceutical Pricing and Reimbursement Policies conference today, Doctors Without Borders/Médecins Sans Frontières...

Read more

As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination

With routine vaccination efforts failing to reach people in fragile and emergency settings, MSF is seeing low vaccination coverage and more outbreaks of vaccine-preventable diseases, like diphtheria and measles  Geneva, 15 April 2024 – Ahead of Gavi, the Vaccine Alliance’s Board...

Read more

Time for $5: MSF demands Cepheid and Danaher lower the price of medical tests

Help us stop the profiteering on medical tests Sign the petition to demand drug manufacturers Cepheid and Danaher drop the price of GeneXpert tests for low- and middle-income countries. MSF and partners protest outside Danaher in Washington, DC, demanding price...

Read more

MSF response to signing of EFTA-India trade agreement

Geneva/Delhi, 12 March 2024: On 10 March 2024, it was announced that India and the European Free Trade Association (EFTA) signed a free trade agreement (FTA) they have been negotiating since 2006. Full text of agreement along with Annex and the Record...

Read more

MSF warns governments are failing to test, treat and prevent TB in children

Governments must immediately implement the latest WHO guidelines to stop children from dying from this deadly yet curable disease  Geneva, 14 November 2023 - Médecins Sans Frontières/Doctors Without Borders (MSF)  welcomed the World Health Organization’s (WHO) ‘Roadmap towards ending TB in...

Read more

MSF responds to groundbreaking news that Johnson & Johnson will not enforce patents on key TB drug bedaquiline in low- and middle-income countries

30 September 2023, Geneva Christophe Perrin, TB Advocacy Pharmacist, MSF Access Campaign: “We welcome Johnson & Johnson’s (J&J) announcement finally paving the way for unfettered access to affordable generic versions of bedaquiline for all people living with drug-resistant tuberculosis (DR-TB) who need...

Read more

MSF: TB test price reduction by Cepheid and Danaher is an important step in the right direction

Cepheid and its parent company Danaher announced today that they are reducing the price of the Xpert MTB/RIF test for TB by 20 percent in high-TB-burden countries from US$9.98 to $7.97 per test.  This reduction is a significant step, considering the...

Read more

Ahead of UN TB High-Level Meeting, US corporations J&J and Cepheid must pledge access to lifesaving TB medicines and tests for everyone in need

TB is curable but remains the world’s leading infectious disease killer 12 September 2023, Geneva/New York – Next week, world leaders meet for the second-ever global tuberculosis (TB) High-Level Meeting at the United Nations (UN) in New York, to endorse...

Read more

MSF South Asia Health and Humanity Summit: Partnering to build better responses during emergencies

17 August 2023, New Delhi: Setting the agenda for a paradigm shift in health and humanitarian considerations during emergencies, especially in South and Southeast Asia, over 15 practitioners, thought leaders, artists, and over 300 attendees from the social impact space...

Read more

Transforming lives in Mozambique: surgical treatment for patients with neglected diseases in Mogovolas district

Nampula, July 21 , 2023 – Médecins Sans Frontières/Doctors Without Borders (MSF) is collaborating with the District Services of Health, Women and Social Action in Mogovolas and the Provincial Services in Nampula, Mozambique, to deliver surgical treatment for hydrocele, one...

Read more

Gavi must do more as WHO/UNICEF estimates show slow childhood vaccination recovery

Gavi should waive co-financing requirements for countries with fragile health systems or in humanitarian crises.Geneva, 18 July, 2023 — Today, Médecins Sans Frontières/Doctors Without Borders (MSF) again called on Gavi, the Vaccine Alliance to broaden “catch-up” vaccine coverage for unprotected...

Read more

MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics

MSF calls again on J&J to withdraw or abandon extended patents on lifesaving TB drug as main patent expires in India today, opening door to more affordable generics. Recent deal offering controlled generics access in limited countries does not go...

Read more
Show Buttons
Share On Facebook
Share On Twitter
Share On Linkedin
Contact us
Hide Buttons